BYSI Stock Summary and Trading Ideas (Beyondspring - | NASDAQ:BYSI)

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Beyondspring - trades on the NASDAQ stock market under the symbol BYSI.

As of April 9, 2025, BYSI stock price climbed to $1.20 with 11,898 million shares trading.

BYSI has a market cap of $48.16 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, BYSI traded as high as $4.00 and as low as $.54.

The top ETF exchange traded funds that BYSI belongs to (by Net Assets): IWC.

BYSI has underperformed the market in the last year with a price return of -53.3% while the SPY ETF gained +7.1%. BYSI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.7% and -22.9%, respectively, while the SPY returned -6.6% and -4.7%, respectively.

BYSI support price is $1.07 and resistance is $1.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BYSI shares will trade within this expected range on the day.